The Organoid Lab integrates fresh tissue acquisition,
processing to culture of patient-specific tumor organoid. We have to date
handled a variety of cancer types, including colorectal cancer (CRC), liver
cancer, glioblastoma (GBM), sarcomas, lung adenocarcinoma, pancreatic
adenocarcinoma and breast cancer, to support laboratory research and personalized
drug testing to inform treatment options.
